Centro de Investigação em Saúde de Manhiça (CISM), CP1929 Maputo, Mozambique.
ISGlobal, Hospital Clínic-Universitat de Barcelona, 08036 Barcelona, Spain.
Biosensors (Basel). 2018 Apr 25;8(2):43. doi: 10.3390/bios8020043.
The appearance, over a decade ago, of continuous glucose monitoring (CGM) devices has triggered a patient-centred revolution in the control and management of diabetes mellitus and other metabolic conditions, improving the patient’s glycaemic control and quality of life. Such devices, the use of which remains typically restricted to high-income countries on account of their elevated costs, at present show very limited implantation in resource-constrained settings, where many other urgent health priorities beyond diabetes prevention and management still need to be resolved. In this commentary, we argue that such devices could have an additional utility in low-income settings, whereby they could be selectively used among severely ill children admitted to hospital for closer monitoring of paediatric hypoglycaemia, a life-threatening condition often complicating severe cases of malaria, malnutrition, and other common paediatric conditions.
十多年前,连续血糖监测 (CGM) 设备的出现引发了糖尿病和其他代谢疾病控制与管理方面的以患者为中心的革命,改善了患者的血糖控制和生活质量。由于成本高昂,这些设备目前在资源有限的环境中应用非常有限,而这些环境中除了糖尿病预防和管理之外,还有许多其他紧迫的卫生重点需要解决。在这篇评论中,我们认为这些设备在低收入环境中可能具有额外的用途,即在因儿科低血糖症而住院接受更密切监测的重病儿童中选择性使用,儿科低血糖症是一种危及生命的病症,常使严重的疟疾、营养不良和其他常见儿科疾病复杂化。